Harmony Biosciences Holdings (HRMY) Stock Price & Financial Analysis
Harmony Biosciences Holdings Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About Harmony Biosciences Holdings
What is the current stock price for HRMY?
As of the latest trading session, HRMY stock trades at $31.38. The 52-week range is $25.52–$40.87, with a day range of $30.34–$31.54.
What is the P/E ratio for HRMY?
Harmony Biosciences Holdings's trailing P/E ratio is 11.2, meaning investors pay $11.2 for every $1 of annual earnings. The forward P/E is 10.6, reflecting analyst expectations for future earnings. Harmony Biosciences Holdings operates in the Healthcare sector.
Does HRMY pay dividends?
Harmony Biosciences Holdings does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for HRMY?
Based on 4 analysts, the consensus for HRMY is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.
What is the market cap of HRMY?
Harmony Biosciences Holdings's market capitalization is $1.84B, classifying it as a small-cap company. Harmony Biosciences Holdings operates in the Healthcare sector within the Biotechnology industry.